
Granules India Ltd. — Investor Relations & Filings
Granules India Ltd. is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The organization maintains a significant global presence through the large-scale production of essential molecules, including Paracetamol, Ibuprofen, Metformin, Methocarbamol, and Guaifenesin. Its business model emphasizes a complete value chain approach, from core chemical synthesis to final product packaging, ensuring operational efficiency and supply chain security. The company serves a diverse international clientele across more than 75 countries, utilizing advanced manufacturing facilities that comply with global regulatory standards. Key strengths include high-volume production capabilities, cost leadership, and a focus on delivering consistent quality in high-demand therapeutic areas.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-05 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | |
| Outcome of Board Meeting | 2026-04-29 | English | |
| Record Date | 2026-04-29 | English | |
| Monitoring Agency Report | 2026-04-29 | English | |
| Press Release | 2026-04-29 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42190443 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-05 | English | ||
| 42184001 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42189199 | Outcome of Board Meeting | 2026-04-29 | English | ||
| 42191621 | Record Date | 2026-04-29 | English | ||
| 42191643 | Monitoring Agency Report | 2026-04-29 | English | ||
| 42193237 | Press Release | 2026-04-29 | English | ||
| 42193327 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42193495 | Change in Management | 2026-04-29 | English | ||
| 42193565 | Outcome of Board Meeting | 2026-04-29 | English | ||
| 42193812 | Outcome of Board Meeting | 2026-04-29 | English | ||
| 42168879 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-16 | English | ||
| 43865664 | Board Meeting — Board Meeting Intimation | 2026-04-16 | English | ||
| 43865676 | Board Meeting — Financial Results/Dividend | 2026-04-16 | English | ||
| 42216151 | Press Release | 2026-04-04 | English | ||
| 42163531 | Disclosure under SEBI Takeover Regulations | 2026-04-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
Granules India Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60224/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60224 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60224 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60224 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60224}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Granules India Ltd. (id: 60224)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.